SEC Form 3 · accession 0001615774-19-002593
Hoth Therapeutics, Inc. · RKTO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Sarnoff
Director
Period of report
Feb 14, 2019
Accepted (ET)
Feb 15, 2019 · 7:42 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001711786
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 25,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The common stock vests in 36 equal monthly installments on the 3rd of every month with the first installment vesting on August 3, 2018.
Remarks
Exhibit 24 - Powers of Attorney